株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

非侵襲血糖値測定

Noninvasive Glucose Measure

発行 Greystone Research Associates 商品コード 650527
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.66円で換算しております。
Back to Top
非侵襲血糖値測定 Noninvasive Glucose Measure
出版日: 2018年06月12日 ページ情報: 英文
概要

当レポートでは、非侵襲血糖値測定市場につて調査し、非侵襲血糖値測定装置における主な設計上の課題、非侵襲血糖値測市場における市場参入企業とその技術、製品開発活動、および事業戦略、経済・技術・規制要因が非侵襲性血糖値モニターの商業化に及ぼす影響などについて、分析しています。

目次

  • エグゼクティブサマリー
  • 血糖値センシング市場の概要
  • 血糖値モニタリング
  • 患者コンプライアンスにおける主な要因
  • 市場成長促進因子
  • 業界の支援と競合情勢
  • 非侵襲血糖値測定の設計要因
  • 組織液における血糖値の測定
  • 患者/ユーザーインターフェース
  • 信頼性
  • データ収集・レポーティング
  • コマーシャルトラックNGM技術
  • 分光法
  • ラマン
  • 赤外線
  • リバースイオントフォレーシス
  • 血糖値測定における最新の応用研究
  • 持続的血糖値モニタリング
  • 短期的非侵襲血糖値測定デバイスの分析
  • 光学データ収集
  • 直接検体測定
  • マルチモードセンシング
  • 予測
  • 重要な民間研究プログラム
  • アジア
  • 北米
  • 欧州
  • 商業化要因
  • 周波数整定
  • 正確さ・精密さ
  • 感度
  • センサー技術・信号処理の進歩
  • 市場要因
  • 規制
  • FDA
  • EMEA
  • アジア (日本)
  • 治験
  • 現在の/継続中の治験
  • 終了した治験
  • 患者/消費者マインド
  • 企業プロファイル
目次
Product Code: NVG469K

Noninvasive glucose monitors have been anticipated by diabetes patients for over a decade. The traditional finger prick method has been a standard disease management tool for decades. But issues of patient compliance and the limitations of current methods in detecting short-term fluctuations in glucose levels have brought a host of companies into the hunt for less invasive and more user-friendly alternatives. Now the convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Noninvasive glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient well-being. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors.

Noninvasive Glucose Measurement - What You Will Learn

  • What are the noninvasive glucose sensing and monitoring technologies that are still being pursued, who are the players behind them, and what is their development status?
  • What are the key noninvasive glucose monitor device design issues and evolving market factors?
  • What is the global market potential for noninvasive glucose monitors today? What will it be in 2024?
  • What will be the likely impact of the availability of commercial noninvasive glucose sensing technology and devices on diabetes management markets?
  • Who are the market participants in the noninvasive glucose monitoring sector? What are their technology, product development activities and business strategies?
  • What will be the impact of economic, technology, and regulatory factors on the commercial potential of noninvasive glucose monitors?

Table of Contents

Summary of Contents

  • Executive Summary
  • Glucose Sensing Market Overview
  • Monitoring Glucose Levels
  • Key Factors in Patient Compliance
  • Market Drivers
  • Industry Alignment and Competitive Landscape
  • Noninvasive Glucose Measurement Design Factors
  • Measuring Glucose in Interstitial Fluid
  • Patient/User Interface
  • Reliability
  • Data Collection & Reporting
  • Commercial Track NGM Technologies
  • Spectroscopy
  • Raman
  • Infrared
  • Reverse Iontophoresis
  • Recent Applied Research in Glucose Measurement
  • Continuous Glucose Monitoring
  • Near-term Noninvasive Glucose Measurement Device Analysis
  • Optical Data Collection
  • Direct Analyte Measurement
  • Multimode Sensing
  • Forecasts
  • Important Private Research Programs
  • Asia
  • North America
  • Europe
  • Commercialization Factors
  • Calibration Frequency
  • Accuracy & Precision
  • Sensitivity
  • Sensor Technology & Signal Processing Advances
  • Market Factors
  • Regulations
  • FDA
  • EMEA
  • Asia (Japan)
  • Clinical Trials
  • Current/Ongoing Clinical Trials
  • Concluded Clinical Trials
  • Patient/Consumer Sentiment
  • Company Profiles
Back to Top